Christal M. M. Mickle

This profile gathers the share dealings of Christal M. M. Mickle in Zevra Therapeutics, Inc. Between 21 April 2015 and 22 March 2017, the trades on record add up to 15 filings.

Purchases make up the whole of the open-market record (4 purchases, €61k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 share grant. In 2017 alone, the filings show 1 purchase and no sales.

In size, the median ticket on the buying side is €15k. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -71.5%. They describe history only and say nothing certain about the share price ahead.

The newest entry dates from 24 March 2017: a transaction, in Zevra Therapeutics, Inc. The most recent open-market purchase was published on 24 March 2017, 3,517 days ago. Typically, a trade is published a median of 28 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.